Moderna, Merck Shares Soar on Cancer Vaccine Trial Success
Investors poured into Moderna and Merck on Wednesday after the two pharmaceutical giants announced a major victory in their fight against skin cancer. A late stage clinical trial revealed that a personalized mRNA vaccine called